US Patent 11389439 Treatment and prevention of ocular neurodegenerative disorder
Patent 11389439 was granted and assigned to The Jackson Laboratory on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Peter Alexander Williams0
Simon W. M. John0
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113894390
Date of Patent
July 19, 2022
0Patent Application Number
159593790
Date Filed
April 23, 2018
0Patent Primary Examiner
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+323 characters)
US Patent 11389439 Treatment and prevention of ocular neurodegenerative disorder
Article
The invention relates to the use of a pharmaceutical composition containing nicotinamide (NAM) and/or pyruvate as a neuroprotective medicament or gene therapy in the treatment of neurodegenerative disorders, in particular axon degeneration of neuronal tissue in ocular-related neurodegeneration diseases including glaucoma.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11389439
Date of patent
July 19, 2022
Patent application number
15959379
Date Filed
April 23, 2018
Patent primary examiner
Find more entities like US Patent 11389439 Treatment and prevention of ocular neurodegenerative disorder
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.